000 00458nam a2200157Ia 4500
008 231101s9999 xx 000 0 und d
020 _a1-57444-882-X
082 _a615.1922
_bROG
100 _aRogge, Mark C.
245 0 _aPreclinical drug development
260 _bTaylor & Francis
_aBoca Raton
_c2005
300 _axiv, 575p. p.
650 _aDrug development ;Drug Evaluation, Preclinical-Methods ;Drug safety
700 _aTaft, David R./
942 _cBK
999 _c5831
_d5831